N. Iwata

Type de document

Co-auteur

M. Ikeda

D. Zhou

F. Zheng

C. Zhang

T.F. Yuan

Y.G. Yao

X. Xiao

L. Wang

C Wang

C.M. van Duijn

A. Takahashi

J. Strohmaier

T.G. Schulze

P.R. Schofield

T. Saito

M. Rietschel

A. Reif

M. Preisig

G. Pistis

M.M. Nöthen

K. Ninomiya

B. Müller-Myhsok

P.B. Mitchell

N.G. Martin

X.J. Luo

M. Li

L. Li

Z. Kutalik

M. Kubo

Y. Kamatani

J. Hecker

M. Grigoroiu-Serbanescu

F.R. Girardin

A.J. Forstner

Y. Fang

S. Cichon

H. Chang

E. Castelao

N. Amin

Date

Source

Serveur académique Lausannois (2)

Mot-clé

risque (2) intérêts (2) Risk (2) Interest (2) administration (1) test (1) pharmacologie (1) association (1) architecture (1) surveillance (1) modèle (1) analyse (1) acide aminé (1) évolution (1) décision (1) activité minière (1) abords (agglomération) (1) public (1) Monitoring (1) Testing (1) Development (1) Costs (1) Diseases (1) Identification (1) Cases (1) Clozapine (1) Genes (1) Testing (1) Strategy (1) State, The (1)

Documents écrit par N. Iwata (2) | parle de N. Iwata (0)

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis.

K. Ninomiya et al. (2022)

Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders.

X. Xiao et al. (11 déc. 2017)